Business Wire

SES

8.6.2020 08:52:12 CEST | Business Wire | Press release

Share
SkyNet de Colombia and SES Networks Ramp Up Connectivity Services to Aid Worst-hit COVID-19 Colombian Amazonas Communities

Local residents, businesses, government entities and the San Rafael de Leticia Hospital in the Colombian Amazonas are experiencing efficient, reliable and high-performing Internet connectivity as Colombian services provider SkyNet and SES Networks extended their partnership and increased network capacity within days to support COVID-19 mitigation efforts. SkyNet leveraged SES Networks’ Signature Solutions to deliver connectivity services to the Colombian region with the highest COVID-19 infection rate and lowest internet penetration in the country, SES announced today.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200607005067/en/

The Colombian Ministry of Telecommunications (MinTIC) selected SkyNet to install, operate and maintain five free Wi-Fi hotspots in Leticia to connect residents, as well as a high -speed dedicated broadband service for the local hospital’s medical and administrative teams to carry out telemedicine sessions and other eHealth activities to effectively respond to the crisis. These services are enabled by SES’s unique low-latency high-throughput O3b medium earth orbit (MEO) satellite constellation , which delivers fibre-equivalent performance to support high-performance data networks and solutions – including cloud services and applications.

According to the MinTIC, the enhanced broadband connectivity service allows local medical staff to communicate with other health professionals in Colombia’s capital Bogotá or institutions around the world. They benefit from tele-consultation services, collaboration with remote teams for faster speed to diagnosis, treatments and follow-ups for patients in the area.

SkyNet has been leveraging SES’s O3b MEO services since 2015 to connect remote Colombian regions, when they first delivered high-speed internet access and fibre-like services in Leticia empowering the local community, businesses and tourism industry. Today, SkyNet has become the incumbent provider in the area delivering reliable connectivity services to hundreds of households and businesses in Leticia, while also enabling access to e-learning platforms for a significant number of local students who cannot travel to attend classes due to the impact of COVID-19.

Additionally, SkyNet is now also leveraging the geostationary SES-14 satellite to enable one Wi-Fi zone for residents, local business and the municipal mayor´s office in Puerto Nariño. This Wi-Fi zone is the local residents’ only way to connect to the Internet as their 2G mobile coverage does not support mobile broadband connectivity.

“Our responsibility and commitment is to have a Colombia that is Naturally Connected. We return to our project in the Amazonas where since 2015 we have linked Leticia’s population to the world helping promote tourism, the main source of income for its inhabitants,” said Diego Moreno Lugo CEO of SkyNet of Colombia. “Today, information and communication technologies bring access to education, remote work and even telemedicine, and it is evident that with the health crisis of COVID-19, remote Colombian regions are worst-hit due to the lack of connectivity. The O3b service experience we are giving is very close to fibre optics and it is the best answer in satellite technology today. It brings great social impact, since it expands opportunities for education and health, and it has been without a doubt a great advancement for this entire community. As a company, we are proud to connect those sometimes-forgotten places.”

“The COVID-19 crisis has impacted us all and we’re committed to doing our part to support our customers and the local communities they serve wherever possible,” said Omar Trujillo, Vice President of Sales for Fixed Data Americas at SES Networks. “By enabling SkyNet to deliver reliable, high-speed broadband connectivity to historically underserved communities, businesses and healthcare workers in the Amazon region when they need it most is extremely gratifying. We are glad that our services are keeping loved ones connected and enabling healthcare workers with tools that empower them to do their job.”

Follow us on:

Social Media
Blog
Media Library

About SES

SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,300 channels and has an unparalleled reach of 367 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .

About SkyNet de Colombia

SkyNet is a Colombian company with more than 20 years in the satellite telecommunications market. SkyNet creates solutions that help customers grow, even in the most remote places in the country; enabling them with the widest spectrum of satellite solutions, based on its own technology and also on services from world-leading providers.

By 2020 SkyNet has established as a priority to have a country where everyone is 'Naturally Connected', consolidating its portfolio with the development of the different Bands of services, an electromagnetic spectrum frequency used in satellite communications that implements more capacity, better coverage and affordable prices. More information: https://www.sky.net.co/

Link:

ClickThru

Social Media:

https://www.facebook.com/SES.Satellites/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release

Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye